HZNP - Horizon Therapeutics Public Limited Company

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
5.81B
Enterprise Value 3
6.31B
Trailing P/E
123.51
Forward P/E 1
16.06
PEG Ratio (5 yr expected) 1
1.27
Price/Sales (ttm)
4.49
Price/Book (mrq)
3.72
Enterprise Value/Revenue 3
4.88
Enterprise Value/EBITDA 6
54.40

Trading Information

Stock Price History

Beta (3Y Monthly) 0.81
52-Week Change 347.85%
S&P500 52-Week Change 318.08%
52 Week High 331.71
52 Week Low 317.94
50-Day Moving Average 328.56
200-Day Moving Average 326.29

Share Statistics

Avg Vol (3 month) 31.21M
Avg Vol (10 day) 31.4M
Shares Outstanding 5187.3M
Float 184.89M
% Held by Insiders 11.20%
% Held by Institutions 182.74%
Shares Short (Oct 31, 2019) 48.17M
Short Ratio (Oct 31, 2019) 46.6
Short % of Float (Oct 31, 2019) 44.48%
Short % of Shares Outstanding (Oct 31, 2019) 44.38%
Shares Short (prior month Sep 30, 2019) 46.99M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 3.57%
Operating Margin (ttm)8.44%

Management Effectiveness

Return on Assets (ttm)1.76%
Return on Equity (ttm)3.73%

Income Statement

Revenue (ttm)1.29B
Revenue Per Share (ttm)7.25
Quarterly Revenue Growth (yoy)3.10%
Gross Profit (ttm)802.57M
EBITDA 115.93M
Net Income Avi to Common (ttm)46.09M
Diluted EPS (ttm)0.25
Quarterly Earnings Growth (yoy)-45.40%

Balance Sheet

Total Cash (mrq)883.96M
Total Cash Per Share (mrq)4.72
Total Debt (mrq)1.38B
Total Debt/Equity (mrq)89.03
Current Ratio (mrq)2.33
Book Value Per Share (mrq)8.33

Cash Flow Statement

Operating Cash Flow (ttm)343.66M
Levered Free Cash Flow (ttm)254.55M